AmyScan Healthcare
Biotechnology
DeepTech
Maharashtra
, India
Founded:
Jan 2024
Founders:
Samir K. Maji, Ranjit Shaw, Bhumi Davda, Sonali Maji
Description:
Patented blood-based alpha-synuclein amplification diagnostic for accurate, minimally invasive Parkinson's disease detection.
Key Highlights:
Funding Raised: ~$0.5M
Diagnostic Accuracy: 90%
Clinical Samples Validated: 150+
Core Problem Statement
The total unavailability of reliable, affordable, and minimally invasive diagnostic tests for Parkinson's disease causes late-stage detection and missed clinical windows for early therapeutic intervention.
Solution Overview
A patented blood-based diagnostic platform utilizing mutant-based amyloid amplification and engineered alpha-synuclein seeds for high-precision biomarker detection. The system provides PCR-like amplification mechanics for early neurodegenerative tracking.
Strategic Engagement Opportunities
AmyScan's patented assay and multicentric clinical data model position it as a strong translational research and biomarker development partner for neurodegeneration institutes, global pharmaceutical majors, and diagnostic networks.
